[1] [2] The most commonly reported adverse effects in clinical trials include gastrointestinal symptoms such as nausea, diarrhoea, vomiting, constipation, and abdominal discomfort, which occur in a significant proportion of patients, particularly during dose escalation
As biofilms are connected to numerous persistent and difficult-to-eradicate infections in clinical environments, studying these interactions is vital for treatment advancement, leading to better clinical outcomes [219, 220]
If side effects persist or worsen beyond week 6, notify your PlexusDx providerdose adjustment or slower titration often resolves ongoing discomfort while maintaining treatment benefits
In this article, well explore everything you need to know about Cagrilintide dosage schedules, what to expect during its use, and how it fits into the larger landscape of metabolic therapiesincluding retatrutide, semaglutide, and compound tirzepatide options